Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 comparison of triptorelin acetate extended-release microspheres versus Diphereline in prostate cancer
CTR20233144Phase 3Active
- Sponsor
- Luye Pharma Group
- Start
- Oct 2023
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of triptorelin in prostate cancer (PCa), sponsored by Luye Pharma Group. Started Oct 2023; status: active.
02
Drugs
triptorelin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on CTR20233144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233144.